Enterprise Financial Services Corp (EFSC)’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $279K | Sell |
1,473
-61
| -4% | -$11.5K | 0.11% | 128 |
|
|
2026
Q1 | $303K | Buy |
1,534
+153
| +11% | +$29.5K | 0.15% | 112 |
|
|
2025
Q4 | $254K | Buy |
1,381
+37
| +3% | +$6.49K | 0.13% | 125 |
|
|
2025
Q3 | $206K | Buy |
+1,344
| New | +$203K | 0.11% | 146 |
|
|
2021
Q4 | – | Sell |
-76
| Closed | -$9K | – | 373 |
|
|
2021
Q3 | $9K | Sell |
76
-583
| -88% | -$67.9K | ﹤0.01% | 329 |
|
|
2021
Q2 | $79K | Buy |
659
+3
| +0.5% | +$329 | 0.01% | 311 |
|
|
2021
Q1 | $66K | Buy |
656
+89
| +16% | +$8.95K | 0.01% | 349 |
|
|
2020
Q4 | $57K | Buy |
567
+7
| +1% | +$741 | 0.01% | 359 |
|
|
2020
Q3 | $61K | Sell |
560
-88
| -14% | -$9.79K | 0.01% | 348 |
|
|
2020
Q2 | $68K | Buy |
648
+64
| +11% | +$6.61K | 0.01% | 330 |
|
|
2020
Q1 | $52K | Buy |
584
+55
| +10% | +$5.18K | 0.01% | 344 |
|
|
2019
Q4 | $53K | Hold |
529
| – | – | 0.01% | 398 |
|
|
2019
Q3 | $47K | Buy |
529
+18
| +4% | +$1.56K | 0.01% | 403 |
|
|
2019
Q2 | $42K | Hold |
511
| – | – | 0.01% | 440 |
|
|
2019
Q1 | $41K | Buy |
511
+76
| +17% | +$5.99K | 0.01% | 443 |
|
|
2018
Q4 | $33K | Hold |
435
| – | – | 0.02% | 294 |
|
|
2018
Q3 | $34K | Hold |
435
| – | – | 0.02% | 342 |
|
|
2018
Q2 | $31K | Buy |
435
+42
| +11% | +$3.02K | 0.02% | 366 |
|
|
2018
Q1 | $27K | Buy |
393
+137
| +54% | +$9.49K | 0.01% | 404 |
|
|
2017
Q4 | $18K | Hold |
256
| – | – | 0.01% | 462 |
|
|
2017
Q3 | $17K | Hold |
256
| – | – | 0.01% | 467 |
|
|
2017
Q2 | $17K | Sell |
256
-19
| -7% | -$1.24K | 0.01% | 479 |
|
|
2017
Q1 | $17K | Sell |
275
-217
| -44% | -$12.6K | 0.01% | 492 |
|
|
2016
Q4 | $27K | Sell |
492
-376
| -43% | -$21.3K | 0.01% | 375 |
|
|
2016
Q3 | $57K | Buy |
868
+376
| +76% | +$24.6K | 0.03% | 248 |
|
|
2016
Q2 | $30K | Buy |
492
+94
| +24% | +$5.46K | 0.02% | 319 |
|
|
2016
Q1 | $22K | Sell |
398
-112
| -22% | -$6.73K | 0.01% | 374 |
|
|
2015
Q4 | $35K | Buy |
510
+36
| +8% | +$2.36K | 0.02% | 309 |
|
|
2015
Q3 | $30K | Buy |
474
+76
| +19% | +$5K | 0.02% | 313 |
|
|
2015
Q2 | $25K | Hold |
398
| – | – | 0.01% | 349 |
|
|
2015
Q1 | $27K | Hold |
398
| – | – | 0.02% | 364 |
|
|
2014
Q4 | $28K | Hold |
398
| – | – | 0.02% | 358 |
|
|
2014
Q3 | $28K | Hold |
398
| – | – | 0.02% | 358 |
|
|
2014
Q2 | $30K | Sell |
398
-24
| -6% | -$1.74K | 0.02% | 356 |
|
|
2014
Q1 | $27K | Sell |
422
-21
| -5% | -$1.36K | 0.02% | 358 |
|
|
2013
Q4 | $26K | Hold |
443
| – | – | 0.02% | 349 |
|
|
2013
Q3 | $23K | Sell |
443
-33
| -7% | -$1.66K | 0.01% | 355 |
|
|
2013
Q2 | $23K | Buy |
+476
| New | +$24.2K | 0.02% | 308 |
|
Other funds holding AZN
EP
IA
Enterprise Financial Services Corp (EFSC)'s AZN Position: Q2 2026 in Review
Enterprise Financial Services Corp (EFSC) reduced its AstraZeneca (AZN) stake by 4% in Q2 2026, selling an estimated $11.5K and leaving 1,473 shares worth $279K. The position accounts for 0.11% of the portfolio, ranked #128.
Enterprise Financial Services Corp (EFSC) first reported a position in AZN in Q2 2013 and has held it in 38 quarters since. The position peaked at $303K in Q1 2026. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Enterprise Financial Services Corp (EFSC) held 1,473 shares of AstraZeneca worth $279K as of Q2 2026.
- Enterprise Financial Services Corp (EFSC) sold 61 AstraZeneca shares in Q2 2026, an estimated $11.5K.
- AstraZeneca made up 0.11% of Enterprise Financial Services Corp (EFSC)'s portfolio in Q2 2026, its #128 holding.
- Enterprise Financial Services Corp (EFSC) first reported a position in AstraZeneca in Q2 2013 and has held it in 38 quarters since.
- Enterprise Financial Services Corp (EFSC)'s AstraZeneca position peaked at $303K in Q1 2026.
- 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q2 2026, filed 4 Aug 2026.